惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

美团技术团队
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
Martin Fowler
Martin Fowler
雷峰网
雷峰网
IT之家
IT之家
小众软件
小众软件
M
MIT News - Artificial intelligence
博客园 - 聂微东
J
Java Code Geeks
Blog — PlanetScale
Blog — PlanetScale
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
A
About on SuperTechFans
G
Google Developers Blog
Engineering at Meta
Engineering at Meta
Recent Announcements
Recent Announcements
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
The GitHub Blog
The GitHub Blog
F
Fortinet All Blogs
C
Check Point Blog
云风的 BLOG
云风的 BLOG
腾讯CDC
H
Help Net Security
Y
Y Combinator Blog
I
InfoQ

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
UnitedHealth Group: Margin Expansion Will Drive Stock Pri...
2026-04-23 · via All Articles on Seeking Alpha

Summary

  • UnitedHealth Group demonstrates early evidence of recovery, with Q1-26 results exceeding expectations across MLR, revenue, and EPS metrics.
  • UNH's margin recovery is ahead of schedule, driven by premium repricing, AI-driven cost savings, and plan restructuring, supporting a raised 2026 EPS target above $18.25.
  • I forecast faster margin expansion, projecting operating margins to reach 8% by 2030, and estimate a $532 fair value per share, implying 54% upside.
  • Risks include persistent elevated MLR, government reimbursement volatility, and execution challenges, but resumed buybacks and a 2.5% yield add near-term catalysts.
Confident Female Radiologist in Medical Imaging Center

Tom Werner/DigitalVision via Getty Images

Brief Recap of My Last Article

In my last article, I made the case that UnitedHealth Group (UNH) remains a fundamentally strong business, despite being temporarily weighed down by elevated medical costs, reimbursement/funding constraints, and

2.79K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of UNH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This article is for informational purposes only and is not intended as a recommendation. The information presented here is based on publicly available data, and I have no knowledge of your individual financial circumstances. It should not be construed as a recommendation or a solicitation to become a client of DocShah Financial, nor does it establish any advisory relationship between you, the reader, and DocShah Financial. It's important to note that conflicts of interest may exist, and I or my clients may have holdings in the stocks discussed and are subject to change at any time without prior notice. Any decision to invest should be based on your own research and consultation with a qualified financial advisor. Investing involves risks, and past performance is not indicative of future results. DocShah Financial or I may stand to gain from stock purchases, and readers should carefully consider their own risk tolerance and financial situation before making any investment decisions. You are fully responsible for any investment outcome.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.